InMed Pharmaceuticals's total assets for Q4 2025 were $15.58B, an increase of 167791.37% from the previous quarter. INM total liabilities were $2.15B for the fiscal quarter, a 94906.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.